Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy

Hepatocyte growth factor and its receptor cMet activate biological pathways necessary for repair and regeneration following kidney injury. Here, we evaluated the clinical role of urinary cMet as a prognostic biomarker in diabetic nephropathy (DN). A total of 218 patients with DN were enrolled in thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yong Chul, An, Jung Nam, Kim, Jin Hyuk, Choi, Young-Wook, Oh, Sohee, Kwon, Sang Ho, Lee, Mi-Young, Lee, Junghun, Jeong, Jae-Gyun, Lim, Chun Soo, Kim, Yon Su, Yang, Seung Hee, Lee, Jung Pyo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109090/
https://www.ncbi.nlm.nih.gov/pubmed/30143691
http://dx.doi.org/10.1038/s41598-018-31121-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109090/
https://www.ncbi.nlm.nih.gov/pubmed/30143691
http://dx.doi.org/10.1038/s41598-018-31121-1

Ejemplares similares